11.01
-0.15 (-1.34%)
| Previous Close | 11.16 |
| Open | 11.09 |
| Volume | 4,751 |
| Avg. Volume (3M) | 9,150 |
| Market Cap | 181,816,944 |
| Price / Sales | 0.590 |
| Price / Book | 0.860 |
| 52 Weeks Range |
| Profit Margin | -15.80% |
| Operating Margin (TTM) | -14.07% |
| Diluted EPS (TTM) | -0.530 |
| Quarterly Revenue Growth (YOY) | -3.90% |
| Total Debt/Equity (MRQ) | 25.49% |
| Current Ratio (MRQ) | 2.17 |
| Operating Cash Flow (TTM) | 1.45 M |
| Levered Free Cash Flow (TTM) | -1.02 M |
| Return on Assets (TTM) | -4.07% |
| Return on Equity (TTM) | -11.51% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Mixed |
| Health Information Services (Global) | Mixed | Mixed | |
| Stock | SHL Telemedicine Ltd | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -5.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 0.0 |
| Average | -0.83 |
|
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Institutions | 21.80% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |